| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 1.0K | 3.4% |
| Total Income | 1.1K | 3.5% |
| Expenditure | 953.61 | 0.7% |
| PBT | 105.47 | 34.6% |
| Net Profit | 64.39 | 39.1% |
| OPM | -1.95% | 4.92pp |
| NPM | 6.28% | 3.38pp |
| EPS | 1.14 | 41.2% |
Aster DM Healthcare Reports 15% YoY Revenue Growth to INR 3,138 Crs. in 9M FY25 and 35% YoY Operating EBITDA Growth to INR 613 Crs.
01 Feb 2025 · 1 Feb 2025, 12:52 am
Summary
Aster DM Healthcare, a leading integrated healthcare service provider in India, announced its financial results for the quarter ended December 31, 2024. The company reported a 15% YoY growth in revenues to INR 3,138 Crs. in 9M FY25 and a 35% YoY growth in operating EBITDA to INR 613 Crs. in 9M FY25.
Key Highlights
- 1
Revenue grew 15% YoY to INR 3,138 Crs. in 9M FY25
- 2
Operating EBITDA grew 35% YoY to INR 613 Crs. in 9M FY25
- 3
Operating margins stood at 19.5% in 9M FY25
- 4
PBT grew by 103% YoY to INR 413 Crs. in 9M FY25
- 5
Adjusted net profit (post NCI) grew by 65% to INR 251 Crs. in 9M FY25
Management Comments
Dr. Azad Moopen
Founder and Chairman, Aster DM Healthcare
We are pleased with the momentum built in the third quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. For 9M FY25, our India business achieved 15% YoY growth, reaching INR 3,138 crores, driven by increased patient volumes and growth in ARPOB. The Operating EBITDA grew by 35% YoY to INR 613 crores and adjusted net profits (post NCI) grew by 65% YoY to INR 251 crores for 9M FY25. A consistent growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins with 9MFY25 Operating EBITDA margins standing at 19.5%.
Informational and educational content only. Not investment advice.